View web version
MM&M Weekly Digest is a weekly roundup of the week's big stories and notable developments in healthcare marketing, delivered every Friday.
This Week's Big Stories
Rethinking Healthcare Communications Through the Prism of Rare Diseases
Merck's IMPROVE-IT trial hits big, supports wider Zetia use
Sanofi offers glimpse of next-gen. insulin strategy
Analyses support Pradaxa safety profile
Ariz. film, entertainment agency adds depth to Fingerpaint
EHRs blur line between marketing and assistance: researchers
PCSK9s stalk Merck's Vytorin
Tufts: drug dev costs have jumped 145%
FDA approves abuse-deterrent Hysingla ER
Gilead buys priority voucher for $125M
Unsealed court documents shed light on opioid marketing
FDA delays rule on generic drug labeling amid controversy
Study finds new benefits in highly promising heart drug
FDA clears new tool for Ebola arsenal
Inovio sticks with prostate cancer drug

For details on how to advertise in MM&M Weekly Digest, please email Doreen Gates

To unsubscribe from the MM&M Weekly Digest click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150

© 2014 Haymarket Media Inc.